Physician Photo

Eli M. Miloslavsky, MD

Vasculitis and Glomerulonephritis Center

Instructor in Medicine, Harvard Medical School Co-Founder Vasculitis and Glomerulonephritis Center

  • Phone: 617-726-7938
Departments
Rheumatology
Department of Medicine
Clinical Interests
ANCA-associated vasculitis
Giant Cell Arteritis
Cryoglobulinemia
Behcet's syndrome
Cutaneous vasculitis
Aortitis
Dermatomyositis
Systemic lupus erythematosus
Locations
Boston: Massachusetts General Hospital
Medical Education
MD, Mount Sinai School of Medicine
Residency, Massachusetts General Hospital
Fellowship, Massachusetts General Hospital
Board Certifications
Internal Medicine, American Board of Internal Medicine
Rheumatology, American Board of Internal Medicine
Gender
Male
Patient Gateway
Yes, learn more
Patient Age Group
Adult
Accepting New Patients
Yes

BiographyDr. Miloslavsky's primary clinical interest is diagnosis and treatment of systemic vasculitis.  As part of the vasculitis group, he has worked extensively on a multicenter randomized trial that established rituximab as an important treatment option in ANCA-associated vasculitis (RAVE trial).  He is currently involved in several ongoing clinical trials in vasculitis that aim to improve the treatment of these conditions.

Dr. Miloslavsky also has a strong interest in medical education.  He currently teaches at MGH and Harvard Medical School where he has received several teaching awards and has published on the role of simulation and peer teaching in medical education. 

Publications

Miloslavsky EM, Specks U, Merkel PA et al. Rituximab for the treatment of relapses in ANCA-associated vasculitis.  Arthritis Rheumatol. 2014 Jul 21.

Miloslavsky E, Unizony S. The heart in vasculitis. Rheum Dis Clin North Am. 2014 Feb;40(1):11-26.

Miloslavsky EM, Specks U, Merkel PA et al. Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2013 Sep;65(9):2441-9.

Unizony S, Arias-Urdaneta L, Miloslavsky EM et al.  Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.  Arthritis Care Res (Hoboken). 2012 Nov;64(11):1720-9.

Rheumatology Associates
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-7938